SRONYX
SRONYX (Levonorgestrel and Ethinyl Estradiol Tablets USP)
Approved
Approval ID
b0c1a495-4cd7-4664-8fe4-714812f53c71
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 4, 2022
Manufacturers
FDA
Mayne Pharma Inc.
DUNS: 867220261
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Levonorgestrel and Ethinyl Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51862-545
Application NumberANDA077681
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel and Ethinyl Estradiol
Product Specifications
Effective DateMarch 4, 2022
FDA Product Classification